miR-139-5p Regulates the Proliferation of Acute Promyelocytic Leukemia Cells by Targeting MNT

Table 1

Clinical characteristics of APL patients.

Patient	Gender	Age	WBC count at diagnosis (×10^9/L)	Peak WBC count (×10^9/L)
Nonleukocytosis group
1	F	36	3.6	7.0
2	M	50	0.4	2.8
3	F	29	1.3	5.1
4	F	41	0.6	3.4
5	M	56	1.0	7.9
6	M	27	3.7	8.3
Leukocytosis group
1	F	44	4.4	65.4
2	F	64	5.1	20.1
3	F	36	0.9	33.8
4	M	25	2.6	43.7
5	M	51	1.3	53.8
6	F	19	0.7	23.6

M: male; F: female; WBC: white blood cell.